Table 3.
Compound | % Efficacy at 10 μM dose
|
||||
---|---|---|---|---|---|
Insulin secretion | ApoE secretion | Wnt pathway | G2M cell cycle | Angiogenesis | |
1 | 6 % | −3 % | 2 % | 95 % | 130 % |
3 | 8 % | −1 % | 3 % | 11 % | 75 % |
5 | 6 % | 9 % | 3 % | 1 % | −6 % |
Compound | % Efficacy at 10 μM dose
|
||||
---|---|---|---|---|---|
Insulin secretion | ApoE secretion | Wnt pathway | G2M cell cycle | Angiogenesis | |
1 | 6 % | −3 % | 2 % | 95 % | 130 % |
3 | 8 % | −1 % | 3 % | 11 % | 75 % |
5 | 6 % | 9 % | 3 % | 1 % | −6 % |